Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Conference Correspondent
ACR 2017
ASCO 2017 - Acute Myeloid Leukemia
ASCO 2017 - Chronic Lymphocytic Leukemia
ASCO 2019 - Chronic Lymphocytic Leukemia
ASCO 2020 - Lung Cancer
ASCO 2021 - GU Highlights
ASH 2016 - Chronic Lymphocytic Leukemia
ASH 2016 - Multiple Myeloma
ASH 2017 - Chronic Lymphocytic Leukemia
ASH 2018 - Chronic Lymphocytic Leukemia
ASH 2019 - Chronic Lymphocytic Leukemia
Conference Highlights ADA
Conference Highlights AHA
Conference Highlights AMCP
Conference Highlights ASCO
Conference Highlights ASH
Conference Highlights Digestive Disease Week
Conference Highlights ISPOR
Conference Highlights NCCN
Conference Highlights SABCS
IDWeek 2018
ACR 2017
,
Conference Correspondent
Long-Term Efficacy and Safety Results of SIRROUND-D Trial of Sirukumab in Patients with Active RA Despite DMARD Treatment
Read More
ACR 2017
,
Conference Correspondent
Upadacitinib (ABT-494) Is Effective in Patients with Active RA with Inadequate Response to Conventional Synthetic DMARDs
Read More
ACR 2017
,
Conference Correspondent
Sarilumab plus DMARDs Lower HbA1c in Diabetic and Nondiabetic Patients with Rheumatoid Arthritis
Read More
ACR 2017
,
Conference Correspondent
Highly Sensitive Cardiac Troponin I Levels in Peripheral Blood Predict CV Events in Patients with RA
Read More
ACR 2017
,
Conference Correspondent
An Updated Integrated Safety Analysis of Baricitinib for the Treatment of Moderate-to-Severe RA
Read More
ACR 2017
,
Conference Correspondent
Active Treatment Leads to Improved Myocardial Function in Patients with Active RA
Read More
ACR 2017
,
Conference Correspondent
Suboptimal EHR Reporting of Clinical Measures in RA Patients Receiving a Biologic or Targeted Synthetic DMARD
Read More
ACR 2017
,
Conference Correspondent
Both Tofacitinib and Baricitinib in Combination with Methotrexate Are Efficacious in Patients with RA
Read More
ACR 2017
,
Conference Correspondent
No Increased Cardiovascular Risk in Patients with RA Who Newly Initiated Tocilizumab versus Abatacept
Read More
ASCO 2017 - Chronic Lymphocytic Leukemia
,
Conference Correspondent
Long-Term Efficacy and Safety with Ibrutinib in Previously Treated CLL: Up to 4 Years’ Follow-Up of the RESONATE Study
Read More
1
2
3
4
5
Page 2 of 8
Results 11 - 20 of 80